Exphar
0421.802.718 · rovalta.com · 22/09/2026
ACTIVE
Exphar
Financial year 2025 · closed on 31/12/2025
Net result
868,5 k €
+119.0% YoY
Revenue
22,9 M €
+2.1% YoY
Equity
5,5 M €
+17.9% YoY
Workforce
27,0 ETP
+12.0% YoY
Overview
What does Exphar do?
Exphar is a Public limited company incorporated in 1981. Its registered office is in Nivelles. It employs on average 27,0 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0421.802.718
Incorporation
27/08/1981
Legal form
Public limited company
Registered office
Avenue Thomas Edison 105
1402 Nivelles · WallonieSee on map
1402 Nivelles · WallonieSee on map
Contributed capital
1 045 620,00 €
Latest accounts
31/12/2025
Average workforce
27,0 ETP
Joint committees (3)
- 100
- 200
- 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Revenue | 22,9 M € | +2.1% | 22,4 M € | +7.1% | 20,9 M € | -0.6% | 21,1 M € | +35.5% | 15,5 M € | +17.1% | 13,3 M € | +5.3% | 12,6 M € | +21.0% | 10,4 M € | +4.0% | 10 M € | +6.7% | 9,4 M € | – | – | – | – | – | – | – | – | – | – | ||||||||||
| EBITDA | 2,1 M € | +35.7% | 1,5 M € | -50.2% | 3,1 M € | +3.8% | 2,9 M € | -6.3% | 3,1 M € | +51.1% | 2,1 M € | -18.5% | 2,6 M € | +23.9% | 2,1 M € | +12.4% | 1,8 M € | +63.9% | 1,1 M € | -4.9% | 1,2 M € | -5.9% | 1,2 M € | +58.6% | 787,4 k € | +17.4% | 670,4 k € | +102% | 331,7 k € | -53.1% | 707,3 k € | +25.7% | 562,6 k € | +78.1% | 315,8 k € | +49.4% | 211,4 k € | -73.1% | 785 k € |
| Operating result | 1,4 M € | +69.2% | 846,7 k € | -37.3% | 1,3 M € | -10.0% | 1,5 M € | -37.1% | 2,4 M € | +70.2% | 1,4 M € | -24.9% | 1,9 M € | +33.7% | 1,4 M € | +14.8% | 1,2 M € | +138% | 510,8 k € | -19.1% | 631,2 k € | -33.1% | 943,5 k € | +116% | 437,2 k € | +6.8% | 409,3 k € | +227% | 125,3 k € | -78.9% | 593 k € | +28.8% | 460,3 k € | +128% | 202,3 k € | +138% | 85,1 k € | -87.5% | 679,4 k € |
| Net result | 868,5 k € | +119% | 396,6 k € | -65.6% | 1,2 M € | +16.9% | 987 k € | -39.2% | 1,6 M € | +81.0% | 897,3 k € | -27.3% | 1,2 M € | +37.3% | 899,4 k € | +38.1% | 651,4 k € | +159% | 252 k € | -36.2% | 395,1 k € | -17.3% | 477,5 k € | +81.7% | 262,7 k € | +27.3% | 206,4 k € | +332% | 47,7 k € | -83.8% | 294,5 k € | +79.8% | 163,8 k € | +54.8% | 105,8 k € | +50.5% | 70,3 k € | -84.7% | 460,2 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 5,5 M € | +17.9% | 4,7 M € | +10.4% | 4,3 M € | -34.7% | 6,5 M € | +20.0% | 5,4 M € | +42.2% | 3,8 M € | -17.1% | 4,6 M € | +36.1% | 3,4 M € | +0.6% | 3,4 M € | +8.2% | 3,1 M € | +3.8% | 3 M € | +15.3% | 2,6 M € | +11.9% | 2,3 M € | +3.5% | 2,2 M € | +10.1% | 2 M € | +2.4% | 2 M € | +17.4% | 1,7 M € | +10.7% | 1,5 M € | +3.9% | 1,5 M € | -1.3% | 1,5 M € |
| Total assets | 14,1 M € | -12.6% | 16,2 M € | -7.3% | 17,4 M € | +4.4% | 16,7 M € | +45.1% | 11,5 M € | +42.1% | 8,1 M € | -3.2% | 8,4 M € | +26.6% | 6,6 M € | -7.0% | 7,1 M € | +4.5% | 6,8 M € | +11.0% | 6,1 M € | +11.9% | 5,5 M € | +48.5% | 3,7 M € | +18.5% | 3,1 M € | +14.6% | 2,7 M € | +13.6% | 2,4 M € | -17.6% | 2,9 M € | +28.6% | 2,3 M € | -7.3% | 2,4 M € | -7.3% | 2,6 M € |
| Cash | 1,8 M € | -10.7% | 2 M € | +90.0% | 1 M € | +118% | 473,3 k € | -32.1% | 697,3 k € | -18.0% | 850,6 k € | -15.2% | 1 M € | +74.4% | 575,2 k € | -40.3% | 964,2 k € | +106% | 468 k € | +19.4% | 392 k € | -35.4% | 606,7 k € | -15.8% | 720,3 k € | +2691% | 25,8 k € | -74.3% | 100,3 k € | -48.3% | 194,1 k € | -14.9% | 228,2 k € | +291% | 58,4 k € | +41.5% | 41,3 k € | -74.8% | 163,8 k € |
| Debts | 8,5 M € | -25.4% | 11,4 M € | -13.0% | 13,1 M € | +32.6% | 9,9 M € | +65.7% | 5,9 M € | +43.6% | 4,1 M € | +14.8% | 3,6 M € | +17.8% | 3,1 M € | -14.2% | 3,6 M € | -0.7% | 3,6 M € | +21.7% | 3 M € | +2.9% | 2,9 M € | +112% | 1,4 M € | +57.0% | 864 k € | +28.2% | 674,2 k € | +69.8% | 397 k € | -67.0% | 1,2 M € | +66.6% | 721,5 k € | -24.6% | 957,2 k € | -15.1% | 1,1 M € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 27,0 ETP | +12.0% | 24,1 ETP | +26.8% | 19,0 ETP | +22.6% | 15,5 ETP | +2.6% | 15,1 ETP | +7.1% | 14,1 ETP | +11.9% | 12,6 ETP | +5.0% | 12,0 ETP | -7.0% | 12,9 ETP | +2.4% | 12,6 ETP | +11.5% | 11,3 ETP | +13.0% | 10,0 ETP | +42.9% | 7,0 ETP | 0.0% | 7,0 ETP | 0.0% | 7,0 ETP | +6.1% | 6,6 ETP | +4.8% | 6,3 ETP | +12.5% | 5,6 ETP | -5.1% | 5,9 ETP | +1.7% | 5,8 ETP |
Estimate
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 4 active · 30 ended
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
H & H PHARMACEUTICALS● Active | 0759.775.660 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/07/2026 | 04/08/2025 | 25/06/2024 | 18/07/2023 | 13/07/2022 | 22/07/2021 |
| General meeting | 15/06/2026 | 02/06/2025 | 17/06/2024 | 26/06/2023 | 07/04/2022 | 21/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 15/06/2026 | 14/07/2026 | French | |
| Full model | 31/12/2024 | 02/06/2025 | 04/08/2025 | French | |
| Full model | 31/12/2023 | 17/06/2024 | 25/06/2024 | French | |
| Full model | 31/12/2022 | 26/06/2023 | 18/07/2023 | French | |
| Full model | 31/12/2021 | 07/04/2022 | 13/07/2022 | French | |
| Full model | 31/12/2020 | 21/06/2021 | 22/07/2021 | French | |
| Full model | 31/12/2019 | 20/05/2020 | 26/08/2020 | French | |
| Full model | 31/12/2018 | 25/04/2019 | 01/08/2019 | French | |
| Full model | 31/12/2017 | 19/04/2018 | 18/06/2018 | French | |
| Full model | 31/12/2016 | 05/05/2017 | 08/05/2017 | French | |
| Abridged model | 31/12/2015 | 07/04/2016 | 29/09/2016 | French | |
| Abridged model | 31/12/2014 | 02/04/2015 | 30/07/2015 | French | |
| Abridged model | 31/12/2013 | 03/04/2014 | 26/08/2014 | French | |
| Abridged model | 31/12/2012 | 04/04/2013 | 19/07/2013 | French | |
| Abridged model | 31/12/2011 | 05/04/2012 | 07/06/2012 | French | |
| Abridged model | 31/12/2010 | 07/04/2011 | 03/08/2011 | French | |
| Abridged model | 31/12/2009 | 01/04/2010 | 23/08/2010 | French | |
| Abridged model | 31/12/2008 | 02/04/2009 | 02/07/2009 | French | |
| Abridged model | 31/12/2007 | 03/04/2008 | 04/06/2008 | French | |
| Abridged model | 31/12/2006 | 05/04/2007 | 23/05/2007 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 4 active · 30 ended
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates01/08/2025DEMISSIONS, NOMINATIONS
- Mandates15/07/2024DEMISSIONS, NOMINATIONS
- Mandates08/08/2023DEMISSIONS, NOMINATIONS
- Mandates06/03/2023DEMISSIONS, NOMINATIONS
- Mandates03/01/2023DEMISSIONS, NOMINATIONS
- Mandates13/10/2022DEMISSIONS, NOMINATIONS
- Capital / shares13/07/2020CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates16/05/2019DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025868,5 k €↑
- 2024Annual accounts 2024396,6 k €↓
- 2023Annual accounts 20231,2 M €↑
- 2022Annual accounts 2022987 k €↓
- 2021Annual accounts 20211,6 M €↑
- 2020Annual accounts 2020897,3 k €↓
- 2019Annual accounts 20191,2 M €↑
- 2018Annual accounts 2018899,4 k €↑
- 2017Annual accounts 2017651,4 k €↑
- 2016Annual accounts 2016252 k €↓
- 2015Annual accounts 2015395,1 k €↓
- 2014Annual accounts 2014477,5 k €↑
- 2013Annual accounts 2013262,7 k €↑
- 2012Annual accounts 2012206,4 k €↑
- 2011Annual accounts 201147,7 k €↓
- 2010Annual accounts 2010294,5 k €↑
- 2009Annual accounts 2009163,8 k €↑
- 2008Annual accounts 2008105,8 k €↑
- 2007Annual accounts 200770,3 k €↓
- 2006Annual accounts 2006460,2 k €
- 27/08/1981IncorporationPublic limited company